Digital Technology-Informed Stroke Rehabilitation

July 6, 2026 updated by: Scott Uhlrich, University of Utah

The goal of this study is to determine the effects of lab and home-based technology guidance during movement training post-stroke. The study will compare movement training informed by lab-based technology to training delivered with technology at home. The main questions it aims to answer are:

  • How well do lab and home-based technologies help individuals post-stroke improve their movement patterns?
  • Is there a difference in improvement between the in-lab and at-home training groups?
  • Which technologies lead to the most improvement?

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

The study is a randomized, controlled feasibility trial investigating rehabilitation to improve movement patterns after stroke. The study will recruit participants who have had a stroke that led to upper-extremity impairment. Individuals will be assigned to one of two digital technology-guided groups. One group will be guided through exercises in a home-based setting, the other will be lab-based.

Participants will engage in training sessions multiple days a week for up to 6 weeks, either in-lab or at home. Both groups will visit the lab weekly for movement assessments.

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • United States
    • Utah
      • Salt Lake City, Utah, United States, 84112
        • Kennecott Mechanical Engineering Building
        • Contact:
          • Scott Uhlrich, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age between 30-85 years.
  • Diagnosis of stroke.
  • Stroke onset of at least six months prior to the time of participation.
  • Fugl Meyer Upper Extremity between 30-50 (mild-moderate)
  • Cognitive skills to consent and actively participate, as indicated by scores of ≥ 24 on the Mini- Mental Status Examination
  • Able to visit lab up to 5x per week for 3 weeks

Exclusion Criteria:

  • Presence of severe aphasia preventing the ability to follow 1-step directions at least 80% of the time.
  • Excessive spasticity of the wrist, elbow, and shoulder, defined as a Modified Ashworth Score >2.
  • Diagnosis of neurological disorders other than stroke.
  • Orthopedic/musculoskeletal conditions (e.g., severe arthritis) affecting the upper extremity.
  • Currently or planning to become pregnant.
  • Participation in concurrent occupational therapy.
  • Unilateral neglect, defined as failure of the Line Bisection Task
  • Upper extremity pain >= 7/10 on Numeric Rating Scale

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: At-Home Training
Participants will train at-home.
Other: Home-based movement guidance
Participants will receive computer-generated guidance on how to perform different activities of daily living efficiently. This guidance will be delivered using home-based technologies, such as a computer or tablet.
Experimental: In-Lab Training
Participants will train in the lab.
Other: Lab-based movement guidance
Participants will receive computer-generated guidance on how to perform different activities of daily living efficiently. The guidance will be delivered using lab-based sensing and feedback technology.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Kinematic movement quality score
Time Frame: From enrollment to the end of treatment at 3 weeks.
A score based on subject kinematics during a daily task (like reaching), comparing the subject's reaching kinematics to normative kinematics.
From enrollment to the end of treatment at 3 weeks.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
FMA-UE Score
Time Frame: From enrollment to the end of treatment at 3 weeks.
Upper Extremity Fugl-Meyer Score
From enrollment to the end of treatment at 3 weeks.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Utah

Investigators

  • Principal Investigator: Scott Uhlrich, PhD, University of Utah

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

July 1, 2026

Primary Completion (Estimated)

December 1, 2033

Study Completion (Estimated)

December 1, 2033

Study Registration Dates

First Submitted

July 6, 2026

First Submitted That Met QC Criteria

July 6, 2026

First Posted (Actual)

July 13, 2026

Study Record Updates

Last Update Posted (Actual)

July 13, 2026

Last Update Submitted That Met QC Criteria

July 6, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • IRB_00203244

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

We will share participant demographics and outcomes data. We will also share kinematics data. These data will be shared on SimTK.org.

IPD Sharing Time Frame

Code and data will be shared upon publication.

IPD Sharing Access Criteria

Code and data will be shared publicly on SimTK.org.

IPD Sharing Supporting Information Type

  • ANALYTIC_CODE

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Home-based movement guidance

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hong Kong

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe